Gender
Item
women
boolean
C0079399 (UMLS CUI [1])
Age
Item
18 years or older
boolean
C0001779 (UMLS CUI [1])
DCIS | Invasive carcinoma of breast TNM Breast tumor staging
Item
ductal carcinoma in situ (dcis) or stage i-iii invasive breast cancer
boolean
C0007124 (UMLS CUI [1])
C0853879 (UMLS CUI [2,1])
C0474926 (UMLS CUI [2,2])
ECOG performance status
Item
eastern cooperative oncology group (ecog) performance status 0-2
boolean
C1520224 (UMLS CUI [1])
Body mass index | Body Weight | Lose weight Percentage Willing
Item
current bmi ≥ 25 kg/m2 and weight ≤ 400 lbs, and willing to lose >5% of their body weight. note: participants may not have documented weight loss greater than 5% of body weight from time of diagnosis. exceptions that are felt to be due to surgical or other procedures (e.g., mastectomies or reconstruction) may be allowed with prior approval of the protocol chair/designee.
boolean
C1305855 (UMLS CUI [1])
C0005910 (UMLS CUI [2])
C1262477 (UMLS CUI [3,1])
C0439165 (UMLS CUI [3,2])
C0600109 (UMLS CUI [3,3])
Local Therapy Completed | Operative Surgical Procedures Completed | Therapeutic radiology procedure Completed | Preoperative Chemotherapy Completed | Adjuvant Chemotherapy Completed | Targeted Therapy HER2 | Hormone Therapy Breast Carcinoma
Item
patients must have completed local therapy (i.e. surgery and radiation therapy), and any preoperative or adjuvant chemotherapy within >3 and <60 months of registration. note: concurrent anti-her2 therapy is permitted. concurrent endocrine breast cancer therapy is permitted; patients may enroll >3 months after initiation of hormone therapy if expected to continue the same hormone agent for at least the first 6 months of the study. concurrent enrollment in other interventional or drug clinical trials is at the discretion of the protocol chair.
boolean
C1517925 (UMLS CUI [1,1])
C0205197 (UMLS CUI [1,2])
C0543467 (UMLS CUI [2,1])
C0205197 (UMLS CUI [2,2])
C1522449 (UMLS CUI [3,1])
C0205197 (UMLS CUI [3,2])
C2347669 (UMLS CUI [4,1])
C0205197 (UMLS CUI [4,2])
C0085533 (UMLS CUI [5,1])
C0205197 (UMLS CUI [5,2])
C2985566 (UMLS CUI [6,1])
C0069515 (UMLS CUI [6,2])
C0279025 (UMLS CUI [7,1])
C0678222 (UMLS CUI [7,2])
Change in diet Willing | Change Physical activity Willing | Body Weight Change Willing
Item
willingness to change diet, physical activity and weight.
boolean
C3671772 (UMLS CUI [1,1])
C0600109 (UMLS CUI [1,2])
C0392747 (UMLS CUI [2,1])
C0026606 (UMLS CUI [2,2])
C0600109 (UMLS CUI [2,3])
C0005911 (UMLS CUI [3,1])
C0600109 (UMLS CUI [3,2])
Compliance Computer software | Compliance Computer Application | Compliance Web Browser | Compliance Internet | Use of Email | Able to read English Language | Able to write English Language
Item
to ensure compliance with the power-remote and patientviewpoint programs, patients must meet the following: prior experience with web forms and feels able to use the power-remote web program and patientviewpoint; has or is able to download internet explorer 8+, firefox 3.0+, safari 4.0+, chrome 4.0+, and adobe flash player 10; familiarity with and access to internet at least 4 days per week; use of an email program or willing and able to establish one for this study; and, able to read and write the english language without assistance.
boolean
C1321605 (UMLS CUI [1,1])
C0037585 (UMLS CUI [1,2])
C1321605 (UMLS CUI [2,1])
C0870325 (UMLS CUI [2,2])
C1321605 (UMLS CUI [3,1])
C3658317 (UMLS CUI [3,2])
C1321605 (UMLS CUI [4,1])
C0282111 (UMLS CUI [4,2])
C1524063 (UMLS CUI [5,1])
C0013849 (UMLS CUI [5,2])
C0586740 (UMLS CUI [6,1])
C0376245 (UMLS CUI [6,2])
C0584993 (UMLS CUI [7,1])
C0376245 (UMLS CUI [7,2])
Comprehension Study Protocol | Informed Consent
Item
patient is aware of her diagnosis, understands the study regimen, its requirements, risks, and discomforts, and is able and willing to sign an informed consent form.
boolean
C0162340 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
C0021430 (UMLS CUI [2])
Cancer Other | Exception Breast Carcinoma | Exception Cone biopsy Carcinoma in situ of uterine cervix Treated | Exception Basal cell carcinoma Treated | Exception Squamous cell carcinoma of skin Treated
Item
history of another prior cancer within the last 5 years, with the exception of another breast cancer, adequately treated cone-biopsied in situ carcinoma of the cervix uteri, and basal or squamous cell carcinoma of the skin
boolean
C1707251 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0678222 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0195324 (UMLS CUI [3,2])
C0851140 (UMLS CUI [3,3])
C1522326 (UMLS CUI [3,4])
C1705847 (UMLS CUI [4,1])
C0007117 (UMLS CUI [4,2])
C1522326 (UMLS CUI [4,3])
C1705847 (UMLS CUI [5,1])
C0553723 (UMLS CUI [5,2])
C1522326 (UMLS CUI [5,3])
Medical condition Interferes with Body Weight Measurement | Condition Weight loss Contraindicated | Condition Causing Weight loss | Condition Affecting Adipokine | Condition Affecting Inflammatory marker | Chronic Kidney Failure Dialysis | Liver Cirrhosis | Autoimmune Disease | Adrenal Gland Diseases | Bariatric Surgery
Item
medical condition likely to hinder accurate measurement of weight, including any condition: for which weight loss is contraindicated, which would likely cause weight loss, or which would affect adipokine and inflammatory markers (e.g., end stage renal disease (esrd) on dialysis, cirrhosis, autoimmune disease, adrenal disease, and history of bariatric surgery).
boolean
C3843040 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C2985231 (UMLS CUI [1,3])
C0348080 (UMLS CUI [2,1])
C1262477 (UMLS CUI [2,2])
C1444657 (UMLS CUI [2,3])
C0348080 (UMLS CUI [3,1])
C0678227 (UMLS CUI [3,2])
C1262477 (UMLS CUI [3,3])
C0348080 (UMLS CUI [4,1])
C0392760 (UMLS CUI [4,2])
C1955907 (UMLS CUI [4,3])
C0348080 (UMLS CUI [5,1])
C0392760 (UMLS CUI [5,2])
C3805088 (UMLS CUI [5,3])
C0022661 (UMLS CUI [6,1])
C0011946 (UMLS CUI [6,2])
C0023890 (UMLS CUI [7])
C0004364 (UMLS CUI [8])
C0001621 (UMLS CUI [9])
C1456587 (UMLS CUI [10])
Insulin | Sulfonylurea | Thyroid Disease | Absence Thyroid preparations Dose Stable | Weight-Loss Agents | topiramate | Bupropion | exenatide | lorcaserin | Phentermine | orlistat | Pharmaceutical Preparations Causing Weight Gain | Pharmaceutical Preparations Preventing Weight loss | Adrenal Cortex Hormones | Lithium | olanzapine | Risperidone | Clozapine | Contraceptives, Oral | Hormone replacement therapy | Pharmaceutical Preparations Affecting Adipokines | Pharmaceutical Preparations Affecting Inflammatory marker | Sulfonylurea | Thiazolidinediones | Insulin | Steroids | Angiotensin-Converting Enzyme Inhibitors | Adrenergic beta-1 Receptor Antagonists | Statins | NSAIDs chronic
Item
the use of the following medications are excluded: insulin or sulfonlyureas; patients with thyroid disease who are not on stable doses of thyroid medication for at least the past 6 months; medications that cause weight loss (e.g., topiramate, bupropion, exenatide, lorcaserin, phentermine or orlistat) within the past 3 months; medications that are likely to cause weight gain or prevent weight loss (e.g., corticosteroids, lithium, olanzapine, risperidone, clozapine, oral contraceptive pills, hormone replacement therapy) within the past 3 months; medications that may affect adipokine or inflammatory markers (e.g., sulfonylureas, glitazones, insulin, steroids, ace inhibitors, beta blockers and statins) unless started ≥3 months prior to enrollment, or chronic nsaids (defined as use of ≥3 times a week) for ≥1 month.
boolean
C0021641 (UMLS CUI [1])
C0038766 (UMLS CUI [2])
C0040128 (UMLS CUI [3])
C0332197 (UMLS CUI [4,1])
C0279175 (UMLS CUI [4,2])
C0178602 (UMLS CUI [4,3])
C0205360 (UMLS CUI [4,4])
C0376606 (UMLS CUI [5])
C0076829 (UMLS CUI [6])
C0085208 (UMLS CUI [7])
C0167117 (UMLS CUI [8])
C2350948 (UMLS CUI [9])
C0031447 (UMLS CUI [10])
C0076275 (UMLS CUI [11])
C0013227 (UMLS CUI [12,1])
C0678227 (UMLS CUI [12,2])
C0043094 (UMLS CUI [12,3])
C0013227 (UMLS CUI [13,1])
C1292733 (UMLS CUI [13,2])
C1262477 (UMLS CUI [13,3])
C0001617 (UMLS CUI [14])
C0023870 (UMLS CUI [15])
C0171023 (UMLS CUI [16])
C0073393 (UMLS CUI [17])
C0009079 (UMLS CUI [18])
C0009905 (UMLS CUI [19])
C0282402 (UMLS CUI [20])
C0013227 (UMLS CUI [21,1])
C0392760 (UMLS CUI [21,2])
C1955907 (UMLS CUI [21,3])
C0013227 (UMLS CUI [22,1])
C0392760 (UMLS CUI [22,2])
C3805088 (UMLS CUI [22,3])
C0038766 (UMLS CUI [23])
C1257987 (UMLS CUI [24])
C0021641 (UMLS CUI [25])
C0038317 (UMLS CUI [26])
C0003015 (UMLS CUI [27])
C0304516 (UMLS CUI [28])
C0360714 (UMLS CUI [29])
C0003211 (UMLS CUI [30,1])
C0205191 (UMLS CUI [30,2])
Pregnancy | Breast Feeding | Pregnancy, Planned
Item
pregnant or nursing within past 6 months, or plans to become pregnant in the next year
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0032992 (UMLS CUI [3])
Enrollment Weight Reduction Program | Enrollment Planned Weight Reduction Program | Other Coding
Item
currently enrolled or planning to enroll in a weight loss program (e.g., innergy, weight watchers, jenny craig, nutrisystem, and medifast).
boolean
C1516879 (UMLS CUI [1,1])
C3179079 (UMLS CUI [1,2])
C1516879 (UMLS CUI [2,1])
C1301732 (UMLS CUI [2,2])
C3179079 (UMLS CUI [2,3])
C3846158 (UMLS CUI [3])